Maruti Suzuki India (MSIL) Earnings: July Sales Reach 180,526 Units

Maruti Suzuki India on Smartkarma

Analyst coverage on Maruti Suzuki India by Sreemant Dudhoria, CFA on Smartkarma reveals a bearish sentiment post their Q4FY25 results. The report titled “Maruti Suzuki India (MSIL) – Top 5 Takeaways from Q4FY25 Results” highlights a disappointing performance with revenue up 6.4% YoY but PAT down 4.3% YoY due to increased costs from new launches and EV investments. Despite management’s optimism to surpass industry growth in FY26 with new SUV launches and strong export growth, the valuation at 25x P/E trailing EPS is deemed fair, suggesting limited near-term upside potential amid subdued demand and margin pressures.

A look at Maruti Suzuki India Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Maruti Suzuki India‘s long-term outlook appears promising based on the Smartkarma Smart Scores analysis. With a strong score of 5 for Growth, the company is expected to exhibit robust expansion potential in the foreseeable future. This suggests that Maruti Suzuki India is well-positioned for significant development and market growth opportunities, indicating a positive trajectory for the company’s future prospects.

Additionally, Maruti Suzuki India received solid scores of 4 for both Dividend and Resilience, indicating a stable dividend payout and the ability to withstand challenging market conditions effectively. While Momentum scored 2, possibly indicating a slower current pace, the overall positive scores suggest that Maruti Suzuki India is a company with promising growth prospects and the ability to weather uncertainties, making it an intriguing prospect for long-term investors.

### Summary of Company Description: Maruti Suzuki India Limited manufactures and exports automobiles. Maruti collaborated with Suzuki of Japan to produce affordable cars for the average Indian. ###

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma